Literature DB >> 7980502

Role of Fas ligand in apoptosis induced by hepatitis C virus infection.

E Mita1, N Hayashi, S Iio, T Takehara, T Hijioka, A Kasahara, H Fusamoto, T Kamada.   

Abstract

To investigate the role that Fas ligand plays in the apoptosis of hepatocytes induced by hepatitis C virus infection, we isolated a cDNA clone for human Fas ligand and examined the expression of Fas ligand in liver-infiltrating mononuclear cells obtained from patients with chronic hepatitis C. The amino acid sequence of human Fas ligand showed 76% and 77% identity with those of rat and mouse Fas ligand, respectively. When the expression of Fas ligand transcripts was tested by reverse transcription-polymerase chain reaction, the amplified signal was detected in liver-infiltrating mononuclear cells and peripheral blood mononuclear cells, whereas only a weak signal or none at all was detected in liver tissues. These findings suggest that the Fas ligand-Fas antigen system may play an important role in liver cell injury by hepatitis C virus infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7980502     DOI: 10.1006/bbrc.1994.2483

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

1.  Expression of perforin and Fas ligand mRNA in the liver of viral hepatitis.

Authors:  M Tagashira; K Yamamoto; K Fujio; T Nagano; R Okamoto; N Ibuki; K Yabushita; S Matsumura; N Okano; T Tsuji
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

2.  Impaired Kupffer cells in highly susceptible mice infected with Trypanosoma congolense.

Authors:  Meiqing Shi; Guojian Wei; Wanling Pan; Henry Tabel
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 3.  Apoptosis: a mechanism of acute and chronic liver injury.

Authors:  M E Guicciardi; G J Gores
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

4.  Induction of Fas-mediated apoptosis on circulating lymphocytes by surgical stress.

Authors:  M Oka; K Hirazawa; K Yamamoto; N Iizuka; S Hazama; T Suzuki; N Kobayashi
Journal:  Ann Surg       Date:  1996-04       Impact factor: 12.969

5.  Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C.

Authors:  M Okazaki; K Hino; K Fujii; N Kobayashi; K Okita
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

6.  Up-regulation of Fas ligand (FasL) mRNA expression in peripheral blood mononuclear cells (PBMC) after major surgery.

Authors:  M Sugimoto; M Shimaoka; K Hosotsubo; H Tanigami; N Taenaka; H Kiyono; I Yoshiya
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

7.  Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway.

Authors:  A Kaser; B Enrich; O Ludwiczek; W Vogel; H Tilg
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

8.  Expression of Fas ligand in liver metastases of human colonic adenocarcinomas.

Authors:  K Shiraki; N Tsuji; T Shioda; K J Isselbacher; H Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

Review 9.  Hepatitis C virus infection and apoptosis.

Authors:  Richard Fischer; Thomas Baumert; Hubert-E Blum
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

10.  Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells.

Authors:  Hee-Jung Yoo; Bo-Ra Yun; Jung-Hee Kwon; Hyuk-Soo Ahn; Min-A Seol; Mi-Jin Lee; Goung-Ran Yu; Hee-Chul Yu; BeeHak Hong; KwanYong Choi; Dae-Ghon Kim
Journal:  Exp Mol Med       Date:  2009-02-28       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.